Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

1.97
Delayed Data
As of Feb 10
 -0.09 / -4.37%
Today’s Change
1.68
Today|||52-Week Range
12.88
-33.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues53.8M33.9M47.0M48.6M
 
 
 
 
 
Cost of Goods Sold14.8M11.1M13.8M12.0M
 
 
 
 
 
Depreciation And Amortization18.7M18.4M22.3M25.7M
 
 
 
 
 
 
Operating ExpensesGross Income20.3M4.4M10.9M10.8M
 
 
 
 
 
General Expenses22.9M22.0M23.2M30.4M
 
 
 
 
 
Research And Development2.3M994.0K1.5M3.2M
 
 
 
 
 
Total Operating Expenses56.4M51.5M59.3M68.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.5M-17.6M-12.4M-19.6M
 
 
 
 
 
Extraordinary Credit0.00--8.7M14.1M
 
 
 
Extraordinary Charge0.00-1.3M-22.5M-1.3M
 
 
 
 
Interest Expense On Debt10.0M9.4M9.9M9.7M
 
 
 
 
 
Other Expenses-82.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.6M-28.2M-35.8M-16.4M
 
 
 
 
 
Income Taxes-4.8M-4.6M-3.6M-5.6M
 
 
 
 
 
Net Income-7.8M-23.7M-32.2M-10.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.3M38.5M52.4M61.0M
 
 
 
 
 
Shares To Calculate EPS Diluted38.3M38.5M52.4M61.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.62-$0.62-$0.18
 
 
 
 
 
EPS Diluted-$0.20-$0.62-$0.62-$0.18